[^1]
[^2]
[^3]
[^4]
| POMT1 (Protein O-Mannosyltransferase 1) |
|---|
| Gene | [POMT1](/genes/POMT1) |
| UniProt | Q9Y4G2 |
| PDB Structures | Not determined |
| Molecular Weight | ~84 kDa |
| Localization | Endoplasmic reticulum |
| Protein Family | Glycosyltransferase family 13 |
POMT1 (Protein O-Mannosyltransferase 1) is an endoplasmic reticulum (ER) membrane-bound enzyme that catalyzes the first step in the O-mannosylation of proteins, particularly α-dystroglycan (α-DG). This post-translational modification is essential for the proper function of dystroglycan at the cell membrane, which serves as a critical link between the extracellular matrix and the cytoskeleton. Mutations in POMT1 cause severe forms of muscular dystrophy with brain involvement, including Walker-Warburg syndrome (WWS) and Limb-Girdle Muscular Dystrophy type 2K (LGMD2K) .
POMT1 is a ~84 kDa protein encoded by the POMT1 gene located on chromosome 9q34.13. It belongs to the glycosyltransferase family 13 and is primarily localized to the endoplasmic reticulum, where it performs its enzymatic function. The protein catalyzes the transfer of mannose from the dolichol-phosphate-mannose donor to specific serine or threonine residues on target proteins, initiating the O-mannosylation pathway.
O-mannosylation is particularly important in muscle and brain tissue, where functional α-dystroglycan is essential for maintaining the structural integrity of muscle fibers and for proper neuronal migration and brain development. The modification involves a cascade of enzymes, with POMT1 initiating the process and POMT2 (Protein O-Mannosyltransferase 2) forming a functional complex [@akasakakamanya2010].
POMT1 possesses the characteristic features of an ER-resident glycosyltransferase:
¶ Domain Organization
- N-terminal signal peptide - Targets the protein to the ER membrane
- Multicopper oxidase-like domain - Predicted domain of unknown function
- Multiple transmembrane regions - Mediates ER membrane association
- ** catalytic domain** - Contains the active site for mannose transfer
- C-terminal ER retrieval signal - Maintains ER localization
POMT1 functions as part of a heterodimeric complex with POMT2:
- POMT1 provides the catalytic activity
- POMT2 assists in substrate recognition
- Both proteins are required for functional enzyme activity
- Complex formation occurs in the ER lumen
POMT1 performs essential biochemical and cellular functions:
The primary enzymatic function is O-mannosylation:
- Catalyzes mannose transfer - First step in O-mannosylation pathway
- Modifies α-dystroglycan - Primary substrate in muscle and brain
- Produces phosphomannan - Creates the mannose-1-phosphate backbone
- Enables downstream glycosylation - Allows Matriglycan formation
Proper O-mannosylation of α-dystroglycan is critical for:
- Basement membrane assembly - Maintains tissue architecture
- Muscle fiber stability - Connects cytoskeleton to extracellular matrix
- Neuromuscular junction formation - Essential for synaptic function
- Neuronal migration - Critical for brain development
- Axon guidance - Facilitates proper neural circuit formation
In muscle tissue:
- Maintains structural integrity of myofibers
- Protects against mechanical stress
- Supports regeneration after injury
In brain:
- Enables neuronal migration during corticogenesis
- Supports formation of the cerebral cortex
- Facilitates cerebellar development
POMT1 mutations cause the most severe form of muscular dystrophy :
Clinical Features:
- Congenital onset - Symptoms present at birth
- Severe muscle weakness - Profound hypotonia
- Brain malformations - Lissencephaly, cobblestone cortex
- Cerebellar hypoplasia - Underdeveloped cerebellum
- Eye involvement - Retinal dysplasia, cataracts, glaucoma
- Hydrocephalus - Ventricular enlargement
- Seizures - Common due to brain malformations
- Prognosis - Typically early death ( infancy)
Pathogenesis:
- Loss of POMT1 activity leads to absent O-mannosylation
- α-Dystroglycan cannot bind extracellular matrix proteins
- Loss of basement membrane integrity in muscle and brain
- Disrupted neuronal migration leads to brain malformations
POMT1 mutations can cause a milder phenotype:
- Later onset - Childhood to adulthood
- Milder muscle weakness - Primarily proximal muscles
- Normal or mildly abnormal brain - May have subtle findings
- Variable progression - Can be slowly progressive
- Cognitive function - Usually normal
- Part of the muscular dystrophy spectrum
- POMT1 mutations identified in some cases
- Similar but milder than WWS
- Includes eye abnormalities and developmental delay
Understanding POMT1 function has informed therapeutic strategies:
- Gene therapy - Viral delivery of functional POMT1
- Enzyme replacement - Recombinant POMT1 protein
- Small molecule activators - Enhance residual enzyme activity
- Substrate supplementation - Bypass strategies using mannose analogs
- Cell therapy - Stem cell transplantation approaches
- Yoshida-Moriguchi T, et al. (2010). O-mannosylphosphorylation of alpha-dystroglycan in muscular dystrophy. Science. 330(6003):686-690
- Martin PT. (2007). Congenital muscular dystrophies involve protein O-mannosyl glycosylation. J Child Neurol. 22(9):1097-1108
- Endo T. (2015). Glycobiology of alpha-dystroglycan and muscular dystrophy. J Biochem. 157(1):1-12
- Muntoni F, et al. (2008). The neuronal involvement in Walker-Warburg syndrome. Brain. 131(Pt 9):2186-2195
- Akasaka-Manya K, et al. (2010). O-mannosylation in disease and development. J Biochem. 148(6):659-667